Traumatic Surgery, Xinxiang Central Hospital, Xinxiang, China.
The Fourth Clinical College of Xinxiang Medical University, Xinxiang, China.
Ann Palliat Med. 2021 Apr;10(4):4563-4571. doi: 10.21037/apm-21-604.
This study aimed to compare the expression of microRNA (miR)-181a and phosphatase and tensin homolog (PTEN) in hypertrophic scar tissue and cells and to explore the effects of miR-181a and PTEN on the proliferation and apoptosis of the human scar fibroblast cell line HSFb.
HSFb cells were transfected with miR-negative control (miR-NC), miR-181a mimics, miR-181a inhibitor, pcDNA3.1-PTEN (pc-PTEN), or small interfence-PTEN (si-PTEN) plasmid using a Lipofectamine 2000 transfection kit. The effects of miR-181a and PTEN on the proliferation and apoptosis of HSFb were determined using a Cell Counting Kit (CCK)-8 experiment and flow cytometry, respectively. The effects of miR-181a and PTEN on the expression of apoptosis-related proteins in HSFb, including type I collagen (Col-1) and type III collagen (Col-3), were measured by western blot. Finally, the relationship between miR-181a and PTEN was explored by the dual-luciferase reporter gene experiment.
The miR-181a in hypertrophic scar tissues and HSFb were significantly up-regulated compared to embryo skin fibroblast (ESF-1) cells and normal tissues (P<0.05), whereas the opposite results were seen for PTEN expression (P<0.05). Inhibiting miR-181a or upregulating the expression of PTEN significantly suppressed the proliferation of HSFb (P<0.05) and induced their apoptosis (P<0.05). Western blot revealed that inhibiting and upregulating miR-181a and PTEN, respectively, decreased the expression of the B-cell lymphoma-2 (Bcl-2), Col-1, and Col-3 proteins in HSFb, but significantly up-regulated the expression of Bcl-2-associated X protein (Bax), cleaved caspase-3 (c-caspase-3), and cleaved caspase-9 (c-caspase-9) (P<0.05). The dual-luciferase reporter gene experiment results confirmed PTEN to be the downstream target gene of miR-181a. Simultaneous upregulation of miR-181a and PTEN expression had no significant effect on the proliferation and apoptosis of HSFb.
miR-181a promotes the up-regulation of Col-1 and Col-3, and regulates the proliferation and apoptosis of HSFb by targeting PTEN, thereby enhancing the formation of hypertrophic scarring (HS). Therefore, miR-181a and PTEN may be potential therapeutic targets for the treatment of HS.
本研究旨在比较增生性瘢痕组织和细胞中微小 RNA(miR)-181a 和磷酸酶张力蛋白同源物(PTEN)的表达,并探讨 miR-181a 和 PTEN 对人瘢痕成纤维细胞系 HSFb 增殖和凋亡的影响。
使用 Lipofectamine 2000 转染试剂盒将 miR-阴性对照(miR-NC)、miR-181a 模拟物、miR-181a 抑制剂、pcDNA3.1-PTEN(pc-PTEN)或小干扰 RNA-PTEN(si-PTEN)质粒转染至 HSFb 细胞。通过细胞计数试剂盒(CCK)-8 实验和流式细胞术分别测定 miR-181a 和 PTEN 对 HSFb 增殖和凋亡的影响。通过 Western blot 测定 miR-181a 和 PTEN 对 HSFb 中细胞凋亡相关蛋白,包括Ⅰ型胶原(Col-1)和Ⅲ型胶原(Col-3)的表达的影响。最后,通过双荧光素酶报告基因实验探讨 miR-181a 和 PTEN 之间的关系。
与胚胎皮肤成纤维细胞(ESF-1)和正常组织相比,增生性瘢痕组织和 HSFb 中的 miR-181a 表达明显上调(P<0.05),而 PTEN 的表达则相反(P<0.05)。抑制 miR-181a 或上调 PTEN 的表达可显著抑制 HSFb 的增殖(P<0.05)并诱导其凋亡(P<0.05)。Western blot 显示,分别抑制和上调 miR-181a 和 PTEN 可降低 HSFb 中 B 细胞淋巴瘤-2(Bcl-2)、Col-1 和 Col-3 蛋白的表达,但显著上调 Bcl-2 相关 X 蛋白(Bax)、裂解的半胱天冬酶-3(c-caspase-3)和裂解的半胱天冬酶-9(c-caspase-9)的表达(P<0.05)。双荧光素酶报告基因实验结果证实 PTEN 是 miR-181a 的下游靶基因。同时上调 miR-181a 和 PTEN 的表达对 HSFb 的增殖和凋亡无显著影响。
miR-181a 通过靶向 PTEN 促进 Col-1 和 Col-3 的上调,并调节 HSFb 的增殖和凋亡,从而增强增生性瘢痕的形成(HS)。因此,miR-181a 和 PTEN 可能是 HS 治疗的潜在治疗靶点。